These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3552720)

  • 1. Pharmacodynamic aspects of aclarubicin with special reference to daunorubicin and doxorubicin.
    Skovsgaard T
    Eur J Haematol Suppl; 1987; 47():7-20. PubMed ID: 3552720
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of aclarubicin with DNA as compared with daunorubicin and doxorubicin.
    Ando S; Sasada M; Uchino H; Kagawa D; Ueda T; Nakamura T
    Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2343-55. PubMed ID: 3471823
    [No Abstract]   [Full Text] [Related]  

  • 3. The anthracycline antineoplastic drugs.
    Young RC; Ozols RF; Myers CE
    N Engl J Med; 1981 Jul; 305(3):139-53. PubMed ID: 7017406
    [No Abstract]   [Full Text] [Related]  

  • 4. Activity of (7) anthracycline related compounds in an doxorubicin sensitive human small cell lung cancer line and its doxorubicin resistant descendant. Activity of doxorubicin, daunorubicin, 4-deoxyrubicin, 4-demethoxydaunorubicin, detorubicin, 4'-epidoxorubicin and mitoxantrone.
    Zijlstra JG; Meijer C; Timmer-Bosscha H; Le TK; de Vries EG; Mulder NH
    Eur J Respir Dis Suppl; 1987; 149():53-5. PubMed ID: 3034649
    [No Abstract]   [Full Text] [Related]  

  • 5. Failure of aclacinomycin and 7-con-O-methylnogarol (7-OMEN) to decrease cardiac guanylate cyclase activity.
    Levey BA; Ruiz E; Rogerson B; Lehotay DC; Levey GS
    Cancer Treat Rep; 1980; 64(10-11):1127-8. PubMed ID: 6109566
    [No Abstract]   [Full Text] [Related]  

  • 6. [New anthracycline antibiotics and derivatives].
    Tatsuta K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular pharmacokinetics of aclacinomycin A in cultured L1210 cells. Comparison with daunorubicin and doxorubicin.
    Zenebergh A; Baurain R; Trouet A
    Cancer Chemother Pharmacol; 1982; 8(2):243-9. PubMed ID: 6955072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of action of calcium antagonists which alter anthracycline resistance.
    Kessel D; Wilberding C
    Biochem Pharmacol; 1984 Apr; 33(7):1157-60. PubMed ID: 6585204
    [No Abstract]   [Full Text] [Related]  

  • 9. Cellular accumulation and disposition of aclacinomycin A.
    Egorin MJ; Clawson RE; Ross LA; Schlossberger NM; Bachur NR
    Cancer Res; 1979 Nov; 39(11):4396-400. PubMed ID: 498071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative nuclear and cellular incorporation of daunorubicin, doxorubicin, carminomycin, marcellomycin, aclacinomycin A and AD 32 in daunorubicin-sensitive and -resistant Ehrlich ascites in vitro.
    Seeber S; Loth H; Crooke ST
    J Cancer Res Clin Oncol; 1980; 98(2):109-18. PubMed ID: 6938517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
    Umezawa H
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):12-8. PubMed ID: 6173340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tunicamycin on anthracycline resistance in P388 murine leukemia cells.
    Chou TH; Kessel D
    Biochem Pharmacol; 1981 Nov; 30(22):3134-6. PubMed ID: 6950722
    [No Abstract]   [Full Text] [Related]  

  • 13. Mutagenicity of eight anthracycline derivatives in five strains of Salmonella typhimurium.
    Marzin D; Jasmin C; Maral R; Mathe G
    Eur J Cancer Clin Oncol; 1983 May; 19(5):641-7. PubMed ID: 6347692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical mechanism for resistance to anthracycline antibiotics.
    Inaba M
    Prog Clin Biol Res; 1986; 223():35-44. PubMed ID: 3468518
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
    Young CW; Raymond V
    Cancer Treat Rep; 1986 Jan; 70(1):51-63. PubMed ID: 2935251
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of vivo doxorubicin (adriamycin) and aclacinomycin administration on guanylate cyclase activity in rat tissue.
    Lehotay DC; Levey BA; Rogerson BJ; Levey GS
    Proc Soc Exp Biol Med; 1981 Sep; 167(4):459-62. PubMed ID: 6116236
    [No Abstract]   [Full Text] [Related]  

  • 17. Biologic properties of three anthracyclines as a function of lipophilicity.
    Kessel D
    Biochem Pharmacol; 1979 Oct; 28(19):3028-30. PubMed ID: 518699
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on the mechanism of drug resistance in tumor cells and a new antitumor antibiotic].
    Tanaka N
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2666-73. PubMed ID: 6210060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of adriamycin accumulation and effectiveness in adriamycin-resistant cells by aclacinomycin A.
    Tapiero H; Boulé D; Trincal G; Fourcade A; Lampidis TJ
    Leuk Res; 1988; 12(5):411-8. PubMed ID: 3164087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthracycline-induced histamine release from rat mast cells.
    Riegel EA; Kaliner M; El-Hage AN; Ferrans VJ; Kawanami O; Herman EH
    Agents Actions; 1982 Oct; 12(4):431-7. PubMed ID: 6184975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.